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Binding of bacterial adhesins to rat glomerular mesangium in vivo. Two
well characterized bacterial adhesins, the 075X fimbriae of Escherichia
co/i and the type-3 fimbriae of Klebsiellae, with in vitro affinities to type
IV and V collagens, respectively, were used to test whether bacterial
components with affinity for glomerular matrix could bind to glomeruli
in vivo. The purified fimbrial proteins were injected into rats, and
kidney samples were studied by immunofluorescence at two hours to
nine months postinjection. The 075X, but not the type-3 fimbriae,
formed mesangial deposits that persisted for months. Preincubation of
the 075X fimbriae with type IV collagen significantly reduced the
glomerular binding. The fimbrial deposits were extracellular, as anti-
075X IgG injected into rats bound to glomeruhi. Proteinuria or histo-
logical damage could not be detected even after passive or active
immunizations of the rats. The results demonstrate that bacterial
adhesins may bind in vivo to and persist in glomeruli by their specific
affinities. The results also indicate that additional factors provided by
the bacteria or the host are needed for glomerular damage to take place.
Many bacteria including the uropathogenic Escherichia coli
strains frequently express fimbriae which mediate bacterial
adhesion to specific receptors on uroepithelial surfaces or in
extracellular matrices [reviewed in 1]. We have previously
shown that the 075X [2] also called Dr [31 fimbnae of E. co/i
have in vitro a highly specific affinity to the 7S aminoterminal
fragment of type IV collagen [4]. Similarly, the type-3 fimbriae
of Kiebsiella pneumoniae [5] show in vitro affinity to type V
collagen [61. Both affinities seem to be based on protein-protein
interactions. The fimbriae have been previously well character-
ized [1—61. We have also shown that the 075X and the type-3
fimbriae bind to renal extracellular matrices in vitro at cryostat
sections human kidneys [6, 7], but binding of bacterial adhesins
to renal tissues in vivo has not been demonstrated.
Acute glomerulonephritis is often associated with known
infections [8—10]. In chronic glomerulonephritis, such as IgA
nephropathy, the etiology is unknown, but microbial infections
have been suspected as causative agents [11]. Microbial anti-
gens deposited in glomeruli could induce in situ immune reac-
tions leading to glomerular damage [12]. Immunofluorescence
studies have indeed demonstrated microbial antigens in glomer-
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uli of patients or experimental animals in viral [13], bacterial
[14, 15], or parasitic [16, 17] infections, but the results have
often been controversial. Septicemic E. coli infections have
been associated with glomerulonephritis in humans [8] and
animals [18], but considering the common occurrence of E. coli
infections such reports are rare. Here we have tested whether
bacterial adhesins bind to glomeruli also in vivo and whether
such binding induces glomerular damage, using these two
well-characterized fimbrial adhesins as model proteins.
Methods
Bacterial proteins
The 075X fimbriae with affinity to type IV collagen [4] were
purified from E. coli strain IHI 1128 as described earlier [2].
Purified type-3 fimbriae from the recombinant E. coli strain
HB1O1(pFK12) expressing cloned type-3-fimbriae genes of
Kiebsiella pneumoniae [5] were available from previous work
[6]. These fimbriae have specific affinity to type V collagen, as
previously shown [6]. For in vitro tissue binding experiments
and intravenous injections, the purified bacterial components
were suspended in phosphate buffered saline (PBS), pH 7.2.
For kinetic studies, the 075X and the type-3 fimbriae were
labeled with 125! (carrier free; Amersham International, Amer-
sham, UK) by the lodogen procedure (Pierce Chemicals Co.,
Rockford, Illinois, USA; [19]). Specific activities obtained were
5.9 Ci/xg for the 075X protein and 4.9 sCi/tg for the type-3
protein.
Antibodies to bacterial adhesins
The rabbit antisera against the 075X and the type-3 fimbrial
proteins have been described earlier [2, 4, 6]. To remove
possible unspecific reactivity with rat tissue sections, the anti-
sera were first incubated at 56°C for 30 minutes followed by
adsorptions at 37°C for one hour and at 4°C overnight with rat
blood cells and kidney homogenates. The antisera were centri-
fuged at 100,000 gmax for 60 minutes and subsequently used to
detect the fimbrial proteins bound to the rat kidney in vitro or in
vivo and also for the isolation of IgG for the in vivo binding
assays (see below). The IgG was isolated by affinity chroma-
tography on a protein A CL-Sepharose 4B column (Pharmacia,
Uppsala, Sweden), as described [20].
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Animals and tissues
Female Sprague-Dawley rats (200 to 300 g; Department of
Bacteriology and Immunology, University of Helsinki, Hel-
sinki, Finland) were used for tissue samples and for the in vivo
binding experiments. For kidney samples, the animals were
anesthetized with diethylether and blood was flushed from the
kidneys by perfusion with PBS via abdominal aorta [20]. Left
kidneys were removed for immunofluorescence (IF) studies,
tissue samples were snap frozen in isopentane cooled with
liquid nitrogen, and stored at —20°C. Right kidneys were
perfused with 3% paraformaldehyde containing 0.05% glutaral-
dehyde in 0.1 M phosphate buffer, pH 7.2 [21], and tissue
samples were processed for semithin frozen sections, and for
light or electron microscopy, as previously described [21, 22].
Binding of bacterial adhesins to rat kidney in vitro
In vitro binding of the 075X fimbriae to 5 jim cryostat
sections of rat kidney was assessed using 075X-coated fluores-
cent microparticles, as described by Westerlund [23]. Briefly,
108 MX Covaspheres particles (Duke Scientific, Palo Alto,
California, USA) coated with the 075X adhesin were incubated
at room temperature for one hour on kidney sections fixed in
3.5% paraformaldehyde at 4°C for 10 minutes. The particles
were in 50 jil of PBS containing 2% (wt/vol) bovine serum
albumin (BSA; Sigma Chemical Co., St. Louis, Missouri, USA)
and 0.1% (vol/vol) Tween 20 (Sigma). After washing three times
in PBS and twice in distilled water, the sections were stained
with hematoxylin for 10 minutes and carefully washed in
distilled water. Finally, the sections were mounted in niceta-
mide for fluorescence microscopy. For a control, similar bind-
ing test was performed with BSA-coated microparticles [23].
Binding of the type-3 fimbriae to rat kidney sections was
confirmed by the indirect immunogold silver staining technique,
as recently described in detail [6].
Binding of bacterial adhesins to rat kidney in vivo
For the preliminary in vivo binding experiments, 10 to 410 jig
of the 075X fimbriae or 180 to 600 jig of the type-3 fimbriae in
1 ml of PBS were injected intravenously into rats. Kidney
samples were taken for immunofluorescence studies at two
hours postinjection. The initial studies suggested that the gb-
merular binding was maximal, as assessed by the indirect IF
technique (see below), after injection of 250 jig of the 075X
fimbriae. Thus this amount was adopted for the subsequent in
vivo binding studies.
To quantitate the amount of the bacterial adhe sins binding to
various rat tissues at two hours to four days postinjection, 2 to
4 jig of 1251-labeled 075X or type-3 fimbriae were mixed with
250 jig of non-labeled fimbriae and injected intravenously into
rats. The animals were anesthetized, blood samples were taken,
and the rats were perfused with PBS via the left ventricle of the
heart before removing kidneys and tissue samples for counting.
To estimate glomerular binding, glomeruli were isolated from
the kidneys of each rat by the differential sieving technique [21].
For the total glomerular binding the rats were assumed to have
30000 glomeruli per kidney [24].
For binding inhibition experiments, 100 jig of the 075X
fimbriae mixed with 2 jig of '251-labeled fimbriae were preincu-
bated at room temperature for 30 minutes with or without 400
jig of type IV or type V collagens (Sigma) solubilized in 0.2% or
0.6% acetic acid [4], respectively. Groups of 3 rats were
injected with each batch of the preincubated fimbriae. At two
hours postinjection the rats were anesthetized, their kidneys
were removed after perfusion via abdominal aorta, and glomer-
uli were isolated for counting, as described above. Student's
t-test was used for statistical evaluation.
Binding of anti-075X IgG to rat glomeruli
To study whether the glomerular deposits of the 075X
fimbriae were extracellular and exposed to circulating antibod-
ies, we injected 1 to 10 mg of the preadsorbed rabbit anti-075X
IgG intravenously into rats one to two days after the fimbrial
injections or into native rats (controls). Kidney samples of the
injected rats were taken at various time intervals postinjection
and studied for the bound rabbit IgG using the direct IF
technique, as described below.
In vivo effects of the bound bacterial proteins
To examine the consequences of the binding of the bacterial
fimbriae to gbomeruli, four experimental groups of rats were
studied. The rats were injected with fimbrial proteins and/or
with rabbit anti-075X IgG and observed for two hours to nine
months thereafter (Table 1). In Group 1, the rats received one
injection of the 075X fimbriae. In Group 2, the rats were first
injected with the 075X fimbriae and one to two days later with
the preadsorbed rabbit-anti-075X IgG. Kidney samples were
studied 5 to 14 days after the first injection. Control rats
received the anti-075X IgG without a preceding injection of the
fimbriae. In Group 3, the rats were first actively immunized
with the 075X fimbriae and injected four days later with the
075X fimbriae. For the first immunization, 100 jig of the 075X
fimbriae in 100 jib of PBS were mixed with 100 jil of Freund's
complete adjuvant (Difco Laboratories, Detroit, Michigan,
USA) and injected subcutaneously in four sites in the backs of
the animals. A booster immunization with 50 jig of 075X
protein was given two months later, and kidney samples were
taken at three months postinjection. In Group 4, the rats were
injected with the type-3 fimbriae and observed for two hours to
four days postinjection.
For anti-075X antibody determinations, serum samples were
taken from the animals at various time intervals. Rat and rabbit
antibodies against the 075X fimbriae were detected by the
ELISA technique, as described below. The urinary protein was
measured from 18-hour samples, as described earlier [25].
Kidney samples were taken for immunohistobogical and histo-
logical studies.
Immunofluorescence
Cryostat sections (5 jim thick) or semithin frozen sections
(0.5 jim thick) of rat kidney were used for IF studies. To detect
the bacterial adhesins bound to rat kidney in vitro, either
fluorescent microspheres or the immunogold technique was
used (see above). To detect the adhesins bound to kidney in
vivo, cryostat sections were fixed in dry acetone at —20°C for 10
minutes and the indirect IF technique was used. Kidney sec-
tions were first incubated at room temperature for 30 minutes
with the preadsorbed rabbit anti-075X or anti-type-3 antisera
diluted 1/20 in PBS. The slides were washed in PBS and
reincubated with rat (Zymed Laboratories, Inc., South San
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Table 1. Immunohistological findings in the kidneys of the rats injected with bacterial fimbriae
Rats injected with
N of
rats
Time
postinjection
Glomerular findings
Group of
rats
ae Anti-075X
lgG mga
'jm'
Fimbriaec
Rabbit
IgG'
Leukocytes/
glomerulusa075X Type-3
Groupl 10 1 2hr — 1.3
50—410 10 2 hr—9 months ++ (10/10) 2.4
Group 2 250
—
1—10
5
11
2
1—2 d/4—12 d
2 hr—4 days
N.T.
N.T.
+ (11/11)
— (0/2)
3.1
2.1
Group 3" 250 5 3 months ++ (5/5) 3.0
Group 4 — 180—600 7 2 hr—4 days + — (4/7) 2.1
a Rats were injected intravenously with fimbrial proteins and/or with rabbit anti-075X lgGb Rats of Group 3 were immunized with 075X fimbriae 4 days before the injection of fimbriae.
Kidney samples were studied for the bound fimbriae by the indirect IF technique using rabbit anti-fimbrial antibodies and FITC-labeled rat
anti-rabbit IgG. ÷ +, + —, and — denote strongly positive, faintly positive, and negative fluorescence. The numbers in parenthesis denote number
positive/number studied; N.T. is not tested.
d Deposits of rabbit IgG were detected by the direct IF technique using FITC-labeled rat anti-rabbit IgG.
Mean number of leukocyte-common antigen-positive leukocytes from 10 glomeruli of each sample.
Time after injection of the 075X fimbriae/time after injection of anti-075X IgG.
Francisco, California, USA) or swine (Dakopatts, Glostrup,
Denmark) anti-rabbit IgG labeled with fluorescein isothiocy-
anate (FITC). Resident and infiltrating glomerular leukocytes
were detected by incubating the cryostat sections first with
monoclonal anti-rat leukocyte-common antigen antibodies
(MRC OX-i; Serotec Ltd., Blackthorn, Bicester, UK) followed
by an incubation with FITC-labeled rat anti-mouse IgG (Boeh-
ringer, Mannheim, Germany). Positive cells were counted from
10 glomeruli of each kidney. Direct IF technique was used to
detect the immune reactants bound to rat kidney in vivo.
Cryostat sections were incubated for 30 minutes with FITC-
conjugated rabbit (Dakopatts) or mouse (affinity purified; Boeh-
ringer Mannheim Biochemicals, Indianapolis, Indiana, USA)
anti-rat IgG, rat or swine anti-rabbit IgG (Dakopatts), and rabbit
anti-rat C3 (Cappel, West Chester, Pennsylvania, USA). After
washing in PBS the slides were mounted with a non-fading
Mowiol mounting medium [26] and studied under Zeiss Stan-
dard fluorescence microscope equipped with epi-illumination
and interference filters for FITC [22].
Antibody determinations
The levels of rat or rabbit antibodies to the O75X fimbriae
present in rat sera were determined by the ELISA technique
[27], using purified 075X fimbriae (5 sg/ml in PBS) as antigens.
The sera were tested in tenfold dilutions starting from dilution
1/100. Alkaline phosphatase-conjugated anti-rat IgG (Serotec)
diluted 1/200 or anti-rabbit IgG (Orion Diagnostica, Espoo,
Finland) diluted 1/500 were used as secondary antibodies.
Histological and electron microscopic studies
For light microscopy 2 to 3 m thick sections were cut from
the paraffin-embedded kidney samples and stained with hema-
toxylin and eosin, periodic acid Schiff, periodic acid silver
methenamine and Masson's trichrome [25]. Samples of kidney
cortex from four rats, each representing one of the four exper-
imental groups (Table 1), were processed for electron micros-
copy, as described earlier [25].
Results
O75Xfimbriae with affinity to type IV collagen bind to
glomeruli in vivo
On the frozen sections of normal human kidney the 075X
fimbriae bound to all renal basement membranes including
glomerular matrix [7]. As shown in Figure 1A, the fimbriae bind
also to frozen sections of rat kidney. We tested the binding by
using fluorescent microparticles coated with purified 075X
fimbriae. The binding was most intense at the basement mem-
branes of renal tubuli, of Bowman's capsules and of renal
interstitium, while the binding to the glomerular matrix was
weaker. The control particles coated with BSA did not bind to
rat kidney (not shown).
To test whether the 075X fimbriae could also bind in vivo to
the glomerular type IV collagen, we injected 10 to 410 zg of
isolated O7SX fimbriae intravenously into rats. At two hours
after injection of 50 jsg of the O75X fimbriae, diffuse mesangio-
capillary deposits of the fimbriae were seen in glomeruli (Fig.
2A, Table I). No deposits were detected in other renal struc-
tures. The deposits were not detectable after injection of 10 j.g
of fimbriae and reached their maximal intensity by visual
observation with 250 pg of injected fimbriae (Figs. lB and 2B).
This amount was used for all subsequent binding experiments.
Another group of rats was injected with 180 to 600 g of
type-3 fimbnae of Kiebsiella sp bacteria with affinity to type V
collagen in vitro [6]. At cryostat sections of normal human
kidney the type-3 fimbnae bind to sites in close vicinity of the
basement membranes of renal tubuli, to Bowman's capsules
and to interstitial areas [6]. A similar in vitro binding pattern
was seen at the rat kidney (not shown). Interestingly the type-3
fimbnae did not bind to rat glomeruli (Fig. 2C; Table 1). Even
after injection of 600 sg of these fimbriae only faint segmental
deposits were detected by immunofluorescence in capillary
loops of some glomeruli.
To study the specificity of the glomerular binding 100 g of
the O75X fimbriae mixed with 2 p.g of 1251-labeled fimbnae were
preincubated in PBS, or in solutions containing 400 pg of type
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exceeding 100 times the deposition of the type-3 fimbriae (Fig.
3).
The radioactivity bound to glomeruli after injection of 125J
labeled 075X fimbriae decreased rapidly in the first four days
(Fig. 3). Also, by the indirect IF technique the glomerular
deposits decreased by time, but remained clearly detectable at
four (Fig. 2D) and nine (Fig. 2E) months after injection.
The glomerular deposits of O75Xfimbriae are extracellular
To study whether the glomerular deposits of the 075X
adhesins were extracellular and exposed to circulating antibod-
ies, we injected anti-075X IgG (1 to 10 mg) intravenously into
rats that had been injected one to two days earlier with the
adhesins. The rabbit IgG bound to the glomeruli giving a mainly
mesangial binding pattern (Fig. 4A) resembling that of the
bound fimbriae (Figs. 2B and 4D). In the semithin frozen
sections rabbit IgG was detected also along the basement
membranes of the peripheral capillary loops and in the walls of
the glomerular arterioles (Fig. 5). This shows that at two days
postinjection appreciable amounts of the 075X adhesin is
bound to the extracellular matrix. The anti-075X IgG did not
bind to the glomeruli of the control rats, not previously injected
with the fimbriae (Table 1).
Fig. 1. Fluorescence micrograph demonstrating binding of the 075X
fimbriae to rat kidney in vitro (A) and in vivo (B). A. Adherence of
fluorescence isothiocyanate (FITC)-labeled microbeads coated with the
075X fimbnae to 5 sm-cryostat section of normal rat kidney. Note
adherence to the basement membrane area of tubuli (arrowheads) and
Bowman's capsule and weaker fluorescence of glomerular matrix. B.
075X fimbriae in the kidney of a rat injected two hours earlier with 250
g of the flmbriae. Cryostat section of the kidney was stained by
indirect IF using rabbit anti-075X antibodies and FITC-labeled anti-
rabbit IgG. Note intensive fluorescence at the mesangial areas of all
glomeruli and lack of fluorescence in other parts of the kidney. Size bar,
80 m.
IV or type V collagen, before injection into rats. At two hours
postinjection the mean counts (± so)/60000 glomeruli of the rats
(3 in each group) injected with fimbriae preincubated in PBS, or
in solutions of type IV, or V collagens were 64106 (± 5070)
cpm, 24865 (± 6419) cpm, or 57593 (± 6489) cpm, respectively.
Thus preincubation with type IV, but not with type V collagen
reduced significantly (P < 0.002) the glomerular binding of the
fimbriae.
The 075X fimbriae bind to the human decay accelerating
factor and agglutinate human erythrocytes [28]. Neither of the
fimbriae agglutinated rat erythrocytes showing that the fimbriae
did not bind to the homologous rat proteins.
Kinetics of O75Xfimbriae in rats
To study how quickly the adhesins are cleared from the
circulation and to quantitate the amounts of fimbrial proteins
that accumulate in glomeruli, we injected iodinated adhesins
intravenously into rats. As shown in Figure 3, both the 075X
and type-3 fimbriae disappeared rapidly from the circulation
showing identical kinetics. Only the 075X fimbriae accumu-
lated in glomeruli. At one day after injection of 250 zg of 075X
fimbriae the total glomerular deposition was 5.1 g per animal,
Glomerular effects of the bound fimbriae
To test whether the deposited fimbrial proteins or immune
reactions against them could induce glomerular injury, we
studied four groups of rats (Table 1). The rats of Groups 1 and
4 were injected only with the bacterial fimbriae. The rats of
Group 2 were, one to two days after injections of the 075X
fimbriae, passively immunized with 1 to 10 mg of the rabbit
anti-075X IgG. The rats of Group 3 were actively immunized
with the 075X fimbriae, and four days later injected with the
075X adhesin.
None of the tested rats had detectable amounts of anti-075X
antibodies in their sera before fimbrial injections. All rats of the
Group 2 had rabbit anti-075X IgG in their blood until 12 days
postinjection, the time when the last kidney samples were
taken. All actively immunized rats of the Group 3 had low titers
of anti-075X antibodies two months after the first immuniza-
tion. Only three of the eight Group 2 rats tested developed such
antibodies.
As shown in Table 1, all rats that received 50 jsg or more of
the 075X fimbriae had diffuse glomerular deposits of this
adhesin at two hours to nine months postinjection (Figs. 2A and
4D). All rats of Group 2 had diffuse mesangial deposits of rabbit
IgG in glomeruli (Figs. 4A and 5A; Table 1).
All rats of Group 3 and seven of the eight rats of Group 2
tested had distinctive mesangiocapillary deposits of rat IgG
(Figs. 4B and 4E) exceeding in intensity the faint background
deposits of the control rats. Faint, granular deposits of C3 were
seen in the glomeruli of 5 of 9, 9 of 11 and I of 5 rats tested of
the Groups 1, 2, and 4, respectively (Figs. 4C and 4F). These
deposits were not seen in untreated control rats.
The light microscopic histology was normal in all animals. No
significant proteinuria or hematuria was detected in the exper-
imental animals. The mean glomerular leukocyte counts tended
to be higher in the immunized rats of Groups 2 and 3 than in the
control rats of Group 4 (Table 1), but the differences did not
reach statistical significance. Electron microscopy of the four
animals studied showed normal glomerular structures without
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Fig. 2. Fluorescence micrograph demonstrating the bacterial fimbria bound to rat kidney in vivo at two hours (A, B, and C), four months (D) and
nine months (E) postinjection ofthefimbriae. The binding was detected by indirect IF as in Fig. lB. A. After injection of 50 g of the 075X flmbriae
weak granular deposits are present in the mesangial area of a glomerulus. B. Intensive mesangial fluorescence after injection of 250 g of the 075X
fimbriac. C. No type-3 fimbriae are detected in the kidney after injection of 310 sg of these flmbriae. D and E demonstrate the presence of the 075X
fimbna in glomeruli at four and nine months, respectively, after injection of 250 jg of the fimbriae. Size bar, 20 jim.
electron dense deposits in the mesangial areas. However, in the
sample taken from a rat of Group 2 (075X131), mononuclear
leukocytes were detected in glomeruli (1 to 3 per section of
glomerulus). These seemed to be located either partly or totally
within the mesangium or subendothelially (Fig. 6).
Discussion
The results of this study show that the 075X adhesins with
affinity to type IV collagen bound in vivo from the circulation to
the glomerular matrix. At least part of the bound fimbriae
remained extracellular and exposed to circulating antibodies.
Once bound the fimbriae persisted in the glomerular mesangium
for months.
The in vivo binding of the 075X fimbriae and the lack of
binding of the type-3 fimbriae to the glomerular matrix suggests
that the observed binding was not merely mesangial trapping of
macromolecules [29], but was due to the specific affinity of the
075X fimbriae to type IV collagen, a major component of the
glomerular matrix [30]. This conclusion is further supported by
the observation that preincubation of the fimbriae with type IV,
but not with type V collagen, significantly reduced their binding
to glomeruli. The type-3 fimbriae have affinity to type V
collagen, which is a minor component of the glomerular matrix
A Glomeruli B Blood
6
4
itE
.22
Time, days after injection
Fig. 3. Kinetics of the 075X (—) and type-3 (----) fimbriae accumu-
lating in rat glomeruli (A) and disappearing from the blood (B).
'251-labeled fimbriae (2 to 3 g) mixed in 250 g of non-labeled fimbriae
were injected intravenously into rats, blood samples were collected,
and after perfusion via heart, glomeruli were isolated for counting of
bound radioactivity. Both fimbriae disappear from the circulation at
same rate, but only the 075X fimbriae show deposition to glomeruli.
1 4 1 4
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Fig. 4. Immunofluorescence micrograph demonstrating immunohistological findings in the kidneys of the rats that received 250 g of the 075X
fimbriae and were immunized passively with 5 mg of the rabbit anti-075X IgG (A, B, and C) or actively with the O75Xfimbriae (D, E, and F). A.
Rabbit IgG bound to the glomerular mesangium 12 days alter injection into a rat injected two days earlier with the 075X fimbriae. The binding
pattern is similar to that of the 075X fimbriae. B and C. Faint mesangiocapillary deposits of rat IgG and C3, respectively, are in glomeruli of the
same rat. D. Deposits of the 075X fimbriae in a glomerulus of a rat actively immunized with the fimbriae. The kidney sample was taken three
months after i.v. injection of the fimbriae. E and F. Faint granular deposits of rat IgG and rat C3, respectively, are in the glomeruli of the actively
immunized rat. Size bar, 20 m.
[31, 32]. There may be several reasons for their failure to bind
to the matrix. First, the amount of type V collagen present in
the glomeruli is much lower than the amount of type IV collagen
[30]. Second, the affinity of the type-3 fimbriae to type V
collagen seems to be weaker than that of the 075X fimbriae [6],
and third, accessibility of the collagen domains for fimbrial
binding may be different. By their physicochemical character-
istics the isolated 075X and the type-3 fimbriae resemble each
other; both are 0.2 to 2 m long filamentous polymeric proteins
of the bacterial outer membrane with molecular weights varying
from 400,000 to several million daltons [2]. The p1 values of
their major structural subunits, as calculated from the published
sequences [3, 5], are quite similar, 4.5 and 4.0, respectively.
Macromolecules like these are rapidly removed from the circu-
lation, as also our results show. The glomerular endothelial
cells with their open endothelial fenestrae allow macromole-
cules of plasma to get into direct contact with the basement
membranes of glomerular capillaries and with the mesangial
matrix [30]. Various macromolecules, including inorganic sus-
pensions, polysaccharides, proteins, and immune complexes
are found in mesangial intercellular spaces within minutes of
injection [29]. Interestingly, the 075X fimbriae seemed to bind
mainly to the mesangium and only faintly along the peripheral
capillary loops, both of which are recognized by injected
anti-type IV collagen antibodies [33]. This may be due to the
fact that bacteria and antibodies often recognize different
epitopes within a target molecule [34], or the large size and the
anionic character of the fimbriae. Large protein aggregates,
especially if they are anionic, are excluded by the size- and
charge-selective filter of the capillary basement membranes and
tend to localize in the mesangial matrix [29, 30]. It is also
possible that the 7S domain of type IV collagen is not accessible
in the peripheral capillary loops or that some of the novel
epithelial type IV collagen chains [35, 36], in contrast to the
mesangial chains, do not bind the fimbriae. It is less likely that
the mesangial localization of the injected 075X fimbriae would
represent binding of immune complexes formed in vivo to the
Fe-receptors of mesangial cells [37], as we could not detect
anti-075X antibodies in native rats.
The glomerular mesangium has several ways to dispose
ra&tS.
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Fig. 5. Semithin (0.5 pjn) frozen section of the kidney of a rat injected with 250 ,.g of O75Xfimbriae and two days later with 20 mg of rabbit
anti-O75XIgG. (A) Four days after antibody injection rabbit IgG is detected mainly in the mesangial areas, but also along the peripheral glomerular
basement membrane (—) and in the wall of a glomerular arteriole (*). (B) Phase contrast view of the same section. Size bar, 30 sm.
deposited macromolecules. These can be phagocytosed or
transported via intercellular channels to efferent capillaries,
urinary space, or juxtaglomerular zone [29, 37]. The bound
075X fimbriae were apparently not effectively phagocytosed,
as they were accessible to the injected anti-075X IgG at least
for two days postinjection and the bound IgG remained in the
mesangium at least for one week. The fimbriae or immune
complexes were not transported or effectively degraded by
extracellular enzymes, as the fimbrial antigens were clearly
detectable in glomeruli for nine months postinjection. It is also
possible that some or all of the antigens remaining in glomeruli
for months were actually intracellular, as we did not make
ultrastructural studies. The E. co/i fimbriae are very stable
structures [38] and resistant to proteolytic enzymes [39, 40],
which may explain their ability to persist in the tissue.
Our results clearly show that a bacterial adhesive protein
complex can bind to its target site in vivo. In addition to 075X
and type-3 fimbriae, other enterobacterial fimbriae [41, 42], and
cell surface proteins of staphylococci and streptococci [re-
viewed in 43] have been reported to bind to components of
extracellular matrices in vitro. Streptococcus pyogenes pos-
sesses heparin-binding proteins which bind to renal basement
membranes at cryostat sections of rabbit kidney and also in
kidneys perfused with the protein [44]. However, our report is
the first to show in vivo binding of bacterial components.
We were not able to demonstrate that the bound fimbriae
cause glomerular injury. There are several explanations for this.
First, the amount of fimbriae deposited in the glomeruli, about
2.5 p.g per kidney, may not be enough to induce an inflamma-
tory response. Studies on nephrotoxic nephritis have shown
that 175 jsg of bound IgG per rat kidney was needed to induce
proteinuria [45, 46]. In support to this glomerular deposition of
C3, a sign of intraglomerular complement activation, was
detected only in some rats and was very weak. Second,
different inbred strains or species may have large variations in
their immune responses. We tested only one strain of rats with
a weak immune response against the fimbnae. Third, in this
study only purified fimbnae were tested for binding. In real
infections additional bacterial components, such as lipopolysac-
charide and hemolysins, may be associated with the fimbriae
and potentiate the glomerular damage [47, 48].
With so few facts known of the causes of chronic glomeru-
lonephritides, it is important to recognize that some bacterial
components may persist in glomeruli for extended periods. In
resemblance to this bacterial components have been found in
chronically inflamed joints for several months without signifi-
cant morphological changes [49]. Our results suggest that the
normal clearance mechanisms of the body can usually control
the consequences of the glomerular deposition of bacterial
antigens. However, it is possible that the bound microbial
antigens can induce glomerular damage in susceptible individ-
uals. In some circumstances adhesion proteins might function
as 'address labels' directing more toxic bacterial components,
such as lipopolysaccharides, to glomerular matrix. This possi-
bility is currently under study.
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Fig. 6. Electron micrograph demonstrating infiltrating leukocyte(s) in the glomerulus of a rat injected with the O75Xfimbriae and two days later
with the rabbit anti-075X IgG. Kidney sample was taken 12 days after the antibody injection. One, possibly two, foreign cells (M; monocyte?) are
protruding into one of the two adjacent mesangial regions (MES) shown. Otherwise the mesangial areas appear normal. Abbreviations are: END,
endothelial cell; EP, epithelial cell; LU, capillary lumen; US, urinary space. Size bar, 1 m.
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